Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis

Aspirin therapy has shown protective effects against hepatocellular carcinoma (HCC) in preclinical studies. However, it is unclear whether aspirin therapy lowers the risk of HCC in patients with alcoholic cirrhosis. A retrospective analysis of data from 949 consecutive patients with alcoholic cirrho...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Shin, Sangdeok, Lee, Sang Hoon, Lee, Minjong, Kim, Ji Hyun, Lee, Wongu, Lee, Hyun Woo, Park, Min Soo, Park, Seungwoo, Kim, Tae Suk, Choi, Dae Hee
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2020
Sujets:
4500
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7478404/
https://ncbi.nlm.nih.gov/pubmed/32118712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires